Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0890
+0.0150 (20.27%)
Sep 4, 2026, 4:00 PM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $12.87 million as of September 8, 2026. Its market cap has increased by 68.79% in one year.
Market Cap
12.87M
Enterprise Value
12.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
ChartMarket Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has decreased from 14.08M to 12.87M, a decrease of -8.57%. That is a compound annual growth rate of -0.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 12.87M | 65.72% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| Finch Therapeutics Group | 16.62M |
| ZIVO Bioscience | 14.95M |
| Anebulo Pharmaceuticals | 14.63M |
| Oncotelic Therapeutics | 14.34M |
| Synlogic | 13.69M |
| Brainstorm Cell Therapeutics | 11.59M |